Article info
Clinical and epidemiological research
Extended report
Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study
- Correspondence to Aatke van der Maas, Sint Maartenskliniek, Rheumatology, Hengstdal 3, Postbus 9011, Nijmegen 6500 GM, The Netherlands; a.vandermaas{at}maartenskliniek.nl
Citation
Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study
Publication history
- Accepted February 26, 2012
- First published April 13, 2012.
Online issue publication
February 09, 2023
Article Versions
- Previous version (9 February 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions